Evidence map›Paper›PMID 35584404›Full record

ReviewCA: a cancer journal for clinicians2022

Navigating financial toxicity in patients with cancer: A multidisciplinary management approach.

Grace L Smith, Matthew P Banegas, Chiara Acquati, Shine Chang, Fumiko Chino, Rena M Conti, Rachel A Greenup, Juliet L Kroll, Margaret I Liang, Maria Pisu and 4 more

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in CA: a cancer journal for clinicians, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 154 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
154citing papers in PubMed, 8 pooled it
63.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

154 citing papers in PubMed, 8 syntheses or guidelines pooled it, 239 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Measures of financial toxicity in cancer survivors: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. The influence of family resilience and benefit finding on the financial toxicity of primary caregivers of patients with advanced cancer: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  20. Article

94 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Grace L SmithDepartment of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0002-3171-2911
Matthew P BanegasDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, California.
Chiara AcquatiGraduate College of Social Work, University of Houston, Houston, Texas.
Shine ChangDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fumiko ChinoDepartment of Radiation Oncology, Affordability Working Group, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0003-0498-488X
Rena M ContiDepartment of Markets, Public Policy, and Law, Boston University School of Business, Boston, Massachusetts.
Rachel A GreenupDivision of Surgical Oncology, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut.
Juliet L KrollDepartment of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Margaret I LiangDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, The University of Alabama at Birmingham, Birmingham, Alabama.
Maria PisuDepartment of Internal Medicine, The University of Alabama, Birmingham, Alabama.
Kristin M PrimmDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Michael E RothDepartment of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Veena ShankaranSeattle Cancer Care Alliance/University of Washington Medicine and Fred Hutchinson Cancer Research Center, Seattle, Washington.
K Robin YabroffSurveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia.
The University of Texas MD Anderson Cancer Center · USUniversity of Alabama at Birmingham · USAmerican Cancer Society · USBoston University · USMemorial Sloan Kettering Cancer Center · USSeattle Cancer Care Alliance · USUniversity of San Diego · USYale University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Legacy Project - Diversity SupplementR01CA237322 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI BANEGAS, MATTHEW P, HENRIKSON, NORA B. · 2019 to 2023
$3.7M
Addressing Cancer-Related Financial Hardship through Delivery of a Proactive Financial Navigation InterventionR01CA248656 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SHANKARAN, VEENA · 2020 to 2025
$3.0M
Economic Strain and Resilience in Cancer Patients: Assessing Patient-Reported Measures of the Burdens of TreatmentK07CA211804 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SMITH, GRACE · 2016 to 2020
$853k
NCI NIH HHS K07 CA211804NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA237322NCI NIH HHS R01 CA248656
6 · The paper itself

Abstract

Approximately one-half of individuals with cancer face personal economic burdens associated with the disease and its treatment, a problem known as financial toxicity (FT). FT more frequently affects socioeconomically vulnerable individuals and leads to subsequent adverse economic and health outcomes. Whereas multilevel systemic factors at the policy, payer, and provider levels drive FT, there are also accompanying intervenable patient-level factors that exacerbate FT in the setting of clinical care delivery. The primary strategy to intervene on FT at the patient level is financial navigation. Financial navigation uses comprehensive assessment of patients' risk factors for FT, guidance toward support resources, and referrals to assist patient financial needs during cancer care. Social workers or nurse navigators most frequently lead financial navigation. Oncologists and clinical provider teams are multidisciplinary partners who can support optimal FT management in the context of their clinical roles. Oncologists and clinical provider teams can proactively assess patient concerns about the financial hardship and employment effects of disease and treatment. They can respond by streamlining clinical treatment and care delivery planning and incorporating FT concerns into comprehensive goals of care discussions and coordinated symptom and psychosocial care. By understanding how age and life stage, socioeconomic, and cultural factors modify FT trajectory, oncologists and multidisciplinary health care teams can be engaged and informative in patient-centered, tailored FT management. The case presentations in this report provide a practical context to summarize authors' recommendations for patient-level FT management, supported by a review of key supporting evidence and a discussion of challenges to mitigating FT in oncology care. CA Cancer J Clin. 2022;72:437-453.

Indexed as

NeoplasmsOncologistsFinancial StressHumansMedical Oncologycare deliverycostfinancial navigationfinancial toxicitymultidisciplinary

Identifiers

PMID35584404
PMCPMC12994614
OpenAlexW4280489560

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.